Amazon (AMZN) Offering Possible 38.89% Return Over the Next 29 Calendar Days

Amazon's most recent trend suggests a bullish bias. One trading opportunity on Amazon is a Bull Put Spread using a strike $1730.00 short put and a strike $1725.00 long put offers a potential 38.89% return on risk over the next 29 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $1730.00 by expiration. The full premium credit of $1.40 would be kept by the premium seller. The risk of $3.60 would be incurred if the stock dropped below the $1725.00 long put strike price.

The 5-day moving average is moving up which suggests that the short-term momentum for Amazon is bullish and the probability of a rise in share price is higher if the stock starts trending.

The 20-day moving average is moving up which suggests that the medium-term momentum for Amazon is bullish.

The RSI indicator is above 80 which suggests that the stock is in overbought territory.

To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here

LATEST NEWS for Amazon

Amazon's Alexa at Marriott hotels
Wed, 20 Jun 2018 09:02:15 +0000
Amazon has partnered with Marriott International to help increase guest access to amenities with Alexa through its voice-controlled device Echo in an attempt to expand its presence in the hospitality industry. Fred Katayama reports.

Forget Amazon and Apple, smaller companies are the real disruptors, says top media exec
Wed, 20 Jun 2018 06:49:00 +0000
It's been a year since Amazon bought Whole Foods in a $13.7 billion deal that sent tremors through the grocery industry. “I think the real disruptors in many, many ways are … the Dollar Shave Clubs of the world, the Kind Bars, the Red Bulls,” Harris Millard told CNBC at the Cannes Lions International Festival of Creativity in France this week.

[$$] CVS Adds Home Delivery With Help From Post Office
Wed, 20 Jun 2018 00:42:15 +0000
CVS Health Corp. has enlisted the U.S. Postal Service for a new home delivery service, as the drugstore giant strives to stave off Amazon.com Inc. and other rivals. CVS struck a deal with the Postal Service to pick up prescriptions at CVS stores and bring them to customers’ homes in one or two days. CVS is rolling out the nationwide service as it fights falling sales in its roughly 9,800 pharmacies and braces for potential competition from Amazon, which has considered launching a prescription offering and has made a bigger push into medical supplies.

Oracle's forecast miss overshadows cloud growth, shares fall
Tue, 19 Jun 2018 22:38:56 +0000
Oracle sees first-quarter adjusted earnings per share to be between 68 cents and 70 cents, below analysts' average estimate of 72 cents. “Oracle's move to change its reporting structure, which masks the performance of its cloud infrastructure and applications segments, overshadowed the Q4 beat,” Daniel Morgan Senior Portfolio Manager Synovus Trust Company said. Morgan said all metrics in the fourth quarter were strong, but due to the disclosure change “investors are wondering if Oracle is trying to hide something in its total cloud revenue”.

Google Buys a Way Into China
Tue, 19 Jun 2018 22:00:00 +0000
JD.com has some pep in its step today after a big cash investment from Google just made its future a little brighter.

Related Posts

 

MarketTamer is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of MarketTamer are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.


This company makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity’s compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.


The content on any of MarketTamer websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The www.MarketTamer.com educational training program and software services are provided to improve financial understanding.


The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.